Oral Evidence May. 08 2024
Committee: Health and Social Care Committee (Department: Department of Health and Social Care)Found: Health and Social Care Committee Oral evidence: Future Cancer: NICE Medicines Appraisal (Enhertu),
Mentions:
1: Alison Thewliss (SNP - Glasgow Central) Liver disease is a leading cause of premature deaths in Scotland, above breast cancer and suicide, and - Speech Link
2: Alison Thewliss (SNP - Glasgow Central) risk of premature death due to cardiovascular disease and a range of cancers, including liver, colon, breast - Speech Link
3: Preet Kaur Gill (LAB - Birmingham, Edgbaston) but colon, breast, prostate, lung and pancreatic cancers, not to mention heart disease. - Speech Link
4: Navendu Mishra (Lab - Stockport) inequalities and a prompt, comprehensive review of adult liver services by NHS England. - Speech Link
Asked by: Dawn Butler (Labour - Brent Central)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what recent assessment she has made of trends in the level of uptake for breast cancer screenings amongst ethnic minority women.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The national breast screening programme does not currently have the capability to routinely cross reference patient’s ethnicity data with uptake data. NHS England has started work to improve its data collection capabilities as part of the development of the new screening IT system, through the Digital Transformation of Screening programme. This will support the collection of population-level data on protected characteristics such as ethnicity, to support services in improving uptake.
More widely, NHS England has developed a national plan to improve uptake, including interventions to address inequalities and screening barriers. This includes ensuring appointments are as convenient as possible, and efforts are focused on areas and groups with low uptake.
Asked by: Caroline Nokes (Conservative - Romsey and Southampton North)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to increase breast cancer screening uptake (a) in general and (b) in (i) areas and (ii) communities where uptake is lowest.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
NHS England has developed a national plan to improve uptake within the breast screening programme, part of which involves interventions to address inequalities and screening barriers. This includes working to ensure that breast screening appointments are as convenient to people as possible and focusing its efforts on low uptake areas and groups. NHS England is also working to ensure they have data, including on protected characteristics, to support services to deliver more targeted initiatives.
Mentions:
1: Mochan, Carol (Lab - South Scotland) Health visitor services are key to that. - Speech Link
2: Cole-Hamilton, Alex (LD - Edinburgh Western) We also know that it has a role to play in protecting mothers from ovarian cancer and breast cancer. - Speech Link
3: Haughey, Clare (SNP - Rutherglen) It lowers the risk of developing breast cancer—particularly in mothers who had their children when they - Speech Link
4: Harper, Emma (SNP - South Scotland) We have strong evidence that it reduces the risk of breast and ovarian cancer, and it is worth repeating - Speech Link
5: Marra, Michael (Lab - North East Scotland) cancer care in NHS Tayside, female access to mental health services and waits of many years for treatment - Speech Link
Mar. 14 2024
Source Page: Waiting times for suspected and diagnosed cancer patients for January 2024Found: Waiting times for suspected and diagnosed cancer patients for January 2024
Asked by: Kirsten Oswald (Scottish National Party - East Renfrewshire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many and what proportion of women who (a) have and (b) do not have multiple sclerosis attended (i) cancer screening appointments, (ii) mammograms and (iii) cervical screening appointments in each of the last five years.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
National Health Service screening programmes do not collect data on an individual’s long-term condition, and therefore no data is available on what proportion of women who have multiple sclerosis, participate in cancer screening programmes.
Under the Equality Act 2010, and the Health and Social Care Act 2012, NHS screening providers have a legal duty to make sure screening services are accessible to everyone, including people with long term conditions, who may have issues with access.
The following table provides data on the percentage of coverage for the three cancer screening programmes, breast, cervical and bowel, within the age groups invited for NHS screenings, in England over the last five years:
| 2016/17 | 2017/18 | 2018/19 | 2019/20 | 2020/21 | 2021/22 |
Breast Screening – ages 50 to 71 years old | 74.9% | 74.6% | 74.2% | 64.2% | 65.3% | 66.4% |
Cervical Screening – ages 25 to 64 years old | 71.4% | 71.9% | 72.2% | 70.2% | 69.9% | 68.7% |
Bowel Screening – ages 60 to 74 years old | 59.2% | 59.5% | 60.5% | 64.3% | 66.1% | 70.3% |
Note: Data for bowel cancer screening is not separated based on sex.
Jan. 30 2024
Source Page: Tax funding of cancer treatment: FOI reviewFound: Tax funding of cancer treatment: FOI review
Jan. 05 2024
Source Page: Digital pathology to improve cancer screening and save livesFound: Digital pathology to improve cancer screening and save lives
Jan. 05 2024
Source Page: Digital pathology to improve cancer screening and save livesFound: Digital pathology to improve cancer screening and save lives